Raynaud's phenomenon during treatment with lisdexamfetamine: risk of cerebral vasospasm?
ABSTRACT Lisdexamfetamine, a prodrug used to treat Attention Deficit/Hyperactivity Disorder in children, adolescents, and adults, is an inactive substance that is converted into its active form (dextroamphetamine) after being metabolized. This conversion primarily occurs in the bloodstream through e...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2025-10-01
|
| Sarja: | Einstein (São Paulo) |
| Aiheet: | |
| Linkit: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082025000100515&tlng=en |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|